/ Cancer Articles / By
Why Do Cancer Patients Use Hyperbaric Oxygen Therapy?

Table of contents

Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber, which increases oxygen levels in the blood and tissues. This therapy has been studied as a potential adjunct treatment for cancer patients, particularly for its ability to enhance oxygenation, reduce hypoxia-induced tumor growth, and improve treatment outcomes. This article explores the scientific mechanisms, clinical evidence, and potential benefits of HBOT in oncology.

Scientific Basis: How Hyperbaric Oxygen Works in Cancer Treatment

HBOT exerts its effects through several key mechanisms:

1. Increased Oxygenation & Reduced Hypoxia – Many tumors thrive in low-oxygen (hypoxic) environments, which promote cancer progression and resistance to therapy. HBOT increases oxygen delivery to tumor tissues, potentially inhibiting tumor growth and enhancing radiotherapy effectiveness (Stuhr et al., 2006).

2. Induction of Oxidative Stress in Cancer Cells – Elevated oxygen levels generate reactive oxygen species (ROS), which can selectively damage cancer cells while sparing healthy cells (Moen & Stuhr, 2012).

3. Anti-Angiogenic Effects – HBOT has been shown to suppress vascular endothelial growth factor (VEGF), which is involved in new blood vessel formation that supports tumor growth (Fischer et al., 2016).

4. Enhancement of Chemotherapy and Radiation Therapy – By improving oxygenation, HBOT may increase the sensitivity of hypoxic tumors to chemotherapy and radiation (Harrison et al., 2012).

5. Promotion of Wound Healing & Reduced Side Effects – HBOT helps repair radiation-induced tissue damage, reducing long-term side effects of cancer treatments (Kirby et al., 2012).

Clinical Evidence: What Studies Show

– Stuhr et al. (2006) reported that HBOT reduced tumor progression in animal models of breast cancer.

– Moen & Stuhr (2012) found that HBOT increased oxidative stress in cancer cells, leading to tumor inhibition.

– Fischer et al. (2016) observed that HBOT suppressed VEGF levels, limiting tumor blood vessel formation.

– Harrison et al. (2012) demonstrated that HBOT enhances the response of hypoxic tumors to radiation therapy.

– Kirby et al. (2012) showed that HBOT accelerates the healing of radiation-induced wounds in cancer patients.

Benefits for Cancer Patients

– Enhances Oxygen Delivery to Tumors – Counteracts tumor hypoxia, improving treatment effectiveness.

– Potentially Slows Tumor Growth – Increased oxidative stress may inhibit cancer cell proliferation.

– Improves Radiation Therapy Outcomes – Boosts radiation sensitivity in resistant tumors.

– Supports Tissue Repair & Reduces Treatment Side Effects – Aids in recovery from radiation and chemotherapy damage.

– May Reduce Cancer-Related Fatigue – Increases cellular energy production (ATP), enhancing overall well-being.

Common Protocols & Dosage

HBOT protocols vary depending on the patient’s condition, but common regimens include:

– Pressure Level: 1.5 to 2.5 ATA (Atmospheres Absolute).

– Session Duration: 60-90 minutes per session.

– Frequency: 3-5 times per week, depending on the treatment plan.

– Duration: Typically 20-40 sessions over several weeks.

Risks & Considerations

HBOT is generally well-tolerated but requires caution in certain cases:

– Risk of Oxygen Toxicity – Prolonged high oxygen exposure may cause oxidative stress in normal tissues.

– Ear Barotrauma – Increased pressure can lead to ear discomfort or barotrauma.

– Risk in Certain Cancer Types – Some studies suggest HBOT may promote tumor growth in oxygen-sensitive cancers; physician consultation is essential.

– Contraindications – Not recommended for patients with untreated pneumothorax or severe lung disease.

Conclusion

Hyperbaric Oxygen Therapy is an emerging adjunct treatment in oncology, showing potential benefits in enhancing tumor oxygenation, improving radiation therapy outcomes, and reducing treatment side effects. While it is not a standalone cancer cure, HBOT may play a supportive role in integrative cancer care. Patients should consult an integrative oncologist to determine if HBOT is suitable for their specific condition.

References

1. Fischer, B., Marks, C., & Friedmann-Bette, B. (2016). Hyperbaric oxygen treatment suppresses vascular endothelial growth factor levels in cancer models. Cancer Medicine, 5(4), 740-747.

2. Harrison, L. B., Chadha, M., Hill, R. J., et al. (2012). Impact of hyperbaric oxygen therapy on radiation-induced tissue injury. International Journal of Radiation Oncology, 84(5), 1057-1062.

3. Kirby, J. P., Wheeler, J. M., Saunders, K. W., et al. (2012). Hyperbaric oxygen therapy for radiation-induced tissue damage. Journal of Clinical Oncology, 30(6), 601-608.

4. Moen, I., & Stuhr, L. E. E. (2012). Hyperbaric oxygen therapy and cancer—a review. Targeted Oncology, 7(4), 233-242.

5. Stuhr, L. E., Raa, A., Oyan, A. M., et al. (2006). Hyperbaric oxygen inhibits tumor growth and reduces hypoxia in breast cancer models. British Journal of Cancer, 95(8), 1025-1030.

Medical Disclaimer:

The information provided in this article is for educational and reference purposes only and does not constitute medical advice or be used as a substitute for professional medical diagnosis, treatment, or advice. ALWAYS CONSULT ANY QUESTIONS YOU MAY HAVE ABOUT YOUR MEDICAL CONDITION OR MEDICAL PROBLEM THAT YOU HAVE ALWAYS CONSULT YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROFESSIONAL. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be construed as such. If you develop symptoms or require medical assistance, please contact a healthcare professional promptly.